Exposure to Silica dust at work can lead to rheumatic diseases
Researchers at Aarhus University and Aarhus University Hospital have found in a new study that exposure to silica dust at work, which is the case especially at workplaces within construction and industry, may lead to autoimmune rheumatic diseases. The results of the study have been published in the International Journal of Epidemiology.
Exposure to silica dust at work, which is the case especially at workplaces within construction and industry, may lead to autoimmune rheumatic diseases.
As the research results from Aarhus University show, exposure to silica dust comes at a cost.
"Exposure to silica dust at work, which is the case especially at workplaces within construction and industry, may lead to autoimmune rheumatic diseases - even at low levels of exposure," says one of the researchers behind the largest study of its kind, Medical Doctor and PhD Signe Hjuler Boudigaard from Aarhus University and Aarhus University Hospital.
Silica dust is formed when flint, sandstone, granite and concrete are grinded or processed in other ways. Some of the dust consists of small particles which - when you inhale them - are carried right down into the smallest parts of the lungs. This so-called respirable dust accumulates in the lungs, where it causes an inflammatory reaction and activates the immune system.
The risk of rheumatic diseases increases
The researchers examined the association between exposure to silica dust and the rheumatic diseases systemic sclerosis, rheumatoid arthritis, lupus erythematosus and small vessel vasculitis, which is a chronic inflammation of the small blood vessels.
They found that the risk of autoimmune rheumatic diseases increased with increasing exposure levels of silica dust. The risk for persons with the highest exposure was one-and-a-half times greater compared to non-exposed people.
The survey comprised 1,541,505 men and 1,470,769 women from the Danish labour force from 1979 to 2015. A total of 17,000 were diagnosed with one of these autoimmune diseases,
and of these, 1,490 had been exposed to silica dust at work. The study shows a clear association between level of exposure to silica dust at work and autoimmune rheumatic disorders, most clearly for systemic sclerosis and rheumatoid arthritis.
"The most important competing factor is tobacco smoking. We accounted for smoking and there was still an association between silica exposure and autoimmune rheumatic diseases. We know that smoking is not randomly distributed in the population, so it was important to take this into account," says Henrik Kolstad, professor at Aarhus University and Aarhus University Hospital and continues:
"In Denmark and Europe, the occupational exposure limit for silica dust is twice the limit in the USA. It's therefore clearly relevant to include our findings when reviewing the current Danish occupational exposure limit"
The next step is to examine whether exposure to silica dust leads to increased levels of antibodies specific for autoimmune rheumatic diseases. According to Henrik Kolstad, the purpose of these studies is to substantiate the causal relationship and gain insight into the possible causal mechanisms.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.